Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

NCT00424333 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Inhaled human insulin

Sponsor

Pfizer